Literature DB >> 22511266

Letter to the editor regarding "A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer" by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197-1202).

Kim D Mooiman, Andrew K L Goey, Irma Meijerman, Jos H Beijnen, Jan H M Schellens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22511266      PMCID： PMC3360914          DOI： 10.1634/theoncologist.2011-0413

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  9 in total

1.  Effects of Sheng-Mai injection on the PRPP synthetase activity in BFU-es and CFU-es from bone marrows of mice with benzene-induced aplastic anemia.

Authors:  L P Liu; J F Liu; Y Q Lu
Journal:  Life Sci       Date:  2001-08-10       Impact factor: 5.037

2.  Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome.

Authors:  A F List; F Brasfield; R Heaton; B Glinsmann-Gibson; L Crook; R Taetle; R Capizzi
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

3.  Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer.

Authors:  S Marsh; G Somlo; X Li; P Frankel; C R King; W D Shannon; H L McLeod; T W Synold
Journal:  Pharmacogenomics J       Date:  2007-01-16       Impact factor: 3.550

4.  A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer.

Authors:  Neora Yaal-Hahoshen; Yair Maimon; Nava Siegelmann-Danieli; Shahar Lev-Ari; Ilan G Ron; Fani Sperber; Noah Samuels; Jacob Shoham; Ofer Merimsky
Journal:  Oncologist       Date:  2011-06-28

5.  Aqueous extracts of Fructus Ligustri Lucidi enhance the sensitivity of human colorectal carcinoma DLD-1 cells to doxorubicin-induced apoptosis via Tbx3 suppression.

Authors:  Jin-fang Zhang; Ming-liang He; Wei-dong Xie; Yang-chao Chen; Marie C M Lin; Ping-chung Leung; Ya-ou Zhang; Hsiang-fu Kung
Journal:  Integr Cancer Ther       Date:  2010-08-11       Impact factor: 3.279

6.  The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.

Authors:  Sin-Chi Chew; Onkar Singh; Xiangai Chen; Rathi Devi Ramasamy; Tejal Kulkarni; Edmund J D Lee; Eng-Huat Tan; Wan-Teck Lim; Balram Chowbay
Journal:  Cancer Chemother Pharmacol       Date:  2011-04-06       Impact factor: 3.333

7.  Identification of novel pregnane X receptor activators from traditional Chinese medicines.

Authors:  Chunna Yu; Xiaojuan Chai; Lushan Yu; Shuqing Chen; Su Zeng
Journal:  J Ethnopharmacol       Date:  2011-04-16       Impact factor: 4.360

8.  The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

Authors:  Harry D Bear; Stewart Anderson; Ann Brown; Roy Smith; Eleftherios P Mamounas; Bernard Fisher; Richard Margolese; Heather Theoret; Atilla Soran; D Lawrence Wickerham; Norman Wolmark
Journal:  J Clin Oncol       Date:  2003-10-14       Impact factor: 44.544

9.  Clinical study on effect of Astragalus Injection and its immuno-regulation action in treating chronic aplastic anemia.

Authors:  Mao-sheng Wang; Jun Li; Hai-xia Di; Zhen-li Li; Shu-Lian Yang; Wei Hou; Jin-yu Yan; Xiao-min Zhao
Journal:  Chin J Integr Med       Date:  2007-06       Impact factor: 1.978
  9 in total
  2 in total

1.  Effect of the botanical formula LCS101 on the anti-cancer effects of radiation therapy.

Authors:  Zoya Cohen; Noah Samuels; Yair Maimon; Raanan Berger
Journal:  J Cancer Res Clin Oncol       Date:  2018-12-06       Impact factor: 4.553

2.  Botanical Formula LCS101: A Multi-Targeted Approach to Cancer Care.

Authors:  Yair Maimon; Noah Samuels; Zoya Cohen; Raanan Berger; David S Rosenthal
Journal:  Integr Cancer Ther       Date:  2018-10-10       Impact factor: 3.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.